ARTICLE | Clinical News
Brimapitide: Ph II data
February 23, 2017 2:11 AM UTC
A double-blind, placebo-controlled, French Phase II trial in 145 patients with post-operative intraocular inflammation showed that a single 900 μg subconjunctival injection of brimapitide given at the...
BCIQ Company Profiles
BCIQ Target Profiles